Tirzepatide Research Compound Specifications

Tirzepatide is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed for controlled laboratory research. Understanding its precise specifications, purity standards, and documentation requirements is essential for researchers planning investigative studies or validating analytical methods. This guide covers the technical parameters and quality assurance protocols that define research-grade tirzepatide compounds.

Molecular and Physical Specifications

Tirzepatide exists as a 39-amino acid peptide with a molecular weight of approximately 4,813 Da. The compound carries a single fatty acid modification on the lysine residue at position 20, which extends its half-life in research applications by increasing albumin binding. For laboratory use, tirzepatide is supplied in lyophilised (freeze-dried) powder form or as a pre-formulated solution in sterile vials. Dr Peptide supplies it as a 20mg lyophilised research vial and as an Alluvi Tirzepatide 40mg pre-filled research pen.

The peptide exhibits high solubility in sterile aqueous solutions and requires appropriate storage conditions—usually between 2–8°C for reconstituted samples and −20°C or colder for long-term preservation of lyophilised material. Researchers should verify storage specifications with the certificate of analysis for each batch.

Tirzepatide Peptide for Controlled Studies

For controlled laboratory research, tirzepatide should meet documented quality standards that exceed typical chemical reagent specifications. Research-grade compounds require documented purity levels, typically above 95%, with minimal endotoxin content and absence of bacterial contamination. This ensures that experimental results reflect the compound's intended biological activity rather than effects from impurities or contaminants.

Researchers conducting in vitro or cellular studies use tirzepatide to investigate GIP and GLP-1 receptor binding kinetics, signal transduction pathways, and metabolic effects under controlled conditions. The compound's dual-receptor mechanism makes it valuable for comparative studies examining receptor selectivity and tissue-specific responses. Pre-filled peptide pens deliver a consistent measured volume, which supports reproducibility across experimental replicates.

Tirzepatide Batch Verification Certificate

Every batch of research-grade tirzepatide must include a certificate of analysis (CoA) documenting identity, purity, and safety parameters. This third-party verification confirms that the compound meets the stated specifications and supports the scientific validity of your research. The certificate typically includes:

Mass spectrometry or high-performance liquid chromatography (HPLC) results confirming molecular identity and purity percentage; water content analysis by Karl Fischer titration; endotoxin testing (LAL assay) to verify acceptable levels for laboratory use; microbial testing confirming absence of bacterial and fungal contamination; and batch-specific documentation linking the material to its manufacturing date and storage conditions.

Batch verification also includes stability data indicating how long the compound remains within specification under defined storage conditions. This information is critical for planning study timelines and ensuring consistency throughout an extended research programme.

Tirzepatide Laboratory Compound Supplier Standards

Selecting a supplier of tirzepatide for controlled studies requires verification that the organisation maintains documented manufacturing standards, conducts independent testing, and provides complete documentation for every batch. Reputable suppliers maintain detailed records of synthesis, purification, and quality control procedures, enabling researchers to trace the compound's provenance and manufacturing history.

Look for suppliers who offer tirzepatide with certificates of analysis from accredited laboratories, batch-specific documentation rather than generic specifications, and clear guidance on storage and handling for your specific research application. The supplier should be transparent about purity specifications, shelf-life data, and any known impurities or related compounds present at trace levels.

A Certificate of Analysis for Dr Peptide's tirzepatide is available on request, and it ships from the UK. Browse the full GLP-1 research peptide range to compare strengths and formats for your protocol.

Documentation and Regulatory Compliance

Research institutions and academic organisations require documented evidence that compounds meet quality standards appropriate to their intended use. The certificate of analysis serves as this documentation, demonstrating that the material meets its stated specifications and suitability for controlled studies. This record supports institutional review boards, funding bodies, and peer-review processes by establishing material provenance and quality assurance.

Maintain batch documentation throughout your research project. This practice enables reproducibility, supports grant reporting requirements, and provides essential reference material if methodology questions arise during peer review or publication.

Storage and Stability Considerations

Tirzepatide stability depends on storage conditions and formulation type. Lyophilised powder typically remains stable for 24 months or longer when stored at −20°C or below in sealed, desiccated containers. Reconstituted solutions are less stable and should be used within defined timeframes specified in the certificate of analysis—typically 2–4 weeks at 2–8°C depending on the formulation and sterility conditions.

Researchers should plan storage capacity accordingly and establish internal stability monitoring if extended research programmes require regular use. Document storage temperatures, opening dates, and any visible changes to the compound's appearance or solution clarity, as these observations inform data interpretation and quality assurance records.